AMENDED & RESTATED SERIES B SECURITIES PURCHASE AGREEMENTSeries B Securities Purchase Agreement • March 31st, 2010 • Health Discovery Corp • Patent owners & lessors • Georgia
Contract Type FiledMarch 31st, 2010 Company Industry JurisdictionTHIS AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made as of the 17th day of November, 2009, by and among HEALTH DISCOVERY CORPORATION, a Georgia corporation (the “Company”), and the investors listed on Schedule A hereto (the “Purchasers”).
AMENDMENT 1 TO SERIES B SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2010 • Health Discovery Corp • Patent owners & lessors
Contract Type FiledMarch 31st, 2010 Company IndustryTHIS AMENDMENT 1 TO THE SECURITIES PURCHASE AGREEMENT (this “Amendment”) is made as of November 1, 2009, by and among HEALTH DISCOVERY CORPORATION, a Georgia corporation (the “Company”), and the investors listed on the signature page hereto (the “Purchasers”).
LICENSE AGREEMENTLicense Agreement • March 31st, 2010 • Health Discovery Corp • Patent owners & lessors • Delaware
Contract Type FiledMarch 31st, 2010 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), effective this 22nd day of August, 2008 (the “Effective Date”), between Health Discovery Corporation, a corporation of the State of Georgia, U.S.A., with its principal place of business at 2 East Bryan Street, Suite # 601, Savannah, Georgia, hereinafter referred to as “HDC”,
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • March 31st, 2010 • Health Discovery Corp • Patent owners & lessors
Contract Type FiledMarch 31st, 2010 Company IndustryThis Amendment (herein, the “Amendment”) to the License Agreement dated as of August 22, 2008 (the “HDC-SPM License”), is entered into by and between Health Discovery Corporation (“HDC”) and Smart Personalized Medicine (“SPM”), effective as of March 11, 2010 (the “Effective Date”). All capitalized terms not otherwise defined in this Amendment shall have the meaning as set forth in the Agreement.
DEVELOPMENT AGREEMENTDevelopment Agreement • March 31st, 2010 • Health Discovery Corp • Patent owners & lessors • Delaware
Contract Type FiledMarch 31st, 2010 Company Industry JurisdictionTHIS DEVELOPMENT AGREEMENT (this “Agreement”) dated as of March 11, 2010 (the “Effective Date”) is entered into among and between SMART PERSONALIZED MEDICINE, LLC, a Delaware limited liability company (“SPM”), having a registered office at 203 NE Front Street, Suite 201, Milford, Kent County, DE 1996, QUEST DIAGNOSTICS INCORPORATED (“QUEST”), having a place of business located at 3 Giralda Farms, Madison, New Jersey 07940 and HEALTH DISCOVERY CORPORATION, a Georgia corporation (“HDC”) having a place of business located at 2 East Bryan Street, Suite 601, Savannah, GA 31401 (each, a “Party,” and collectively, the “Parties”).
LICENSE AGREEMENTLicense Agreement • March 31st, 2010 • Health Discovery Corp • Patent owners & lessors • Delaware
Contract Type FiledMarch 31st, 2010 Company Industry JurisdictionTHIS LICENSE AGREEMENT dated as of March 11, 2010 (this “Agreement”), is entered into among and between SMART PERSONALIZED MEDICINE, LLC al Delaware corporation (“SPM”), having a place of business at 203 NE Front Street, Suite 101, Milford, Kent County, Delaware 19963, HEALTH DISCOVERY CORPORATION, a Georgia corporation (“HDC”) having a place of business at 2 East Bryan Street, Suite 601, Savannah, GA 31401, and QUEST DIAGNOSTICS, INCORPORATED, a Delaware corporation (“QUEST”), having a place of business at 3 Giralda Farms, Madison, New Jersey 07940 (each, a “Party,” and collectively, the “Parties”).
MUTUAL TERMINATION AND RELEASE AGREEMENTMutual Termination and Release Agreement • March 31st, 2010 • Health Discovery Corp • Patent owners & lessors • Delaware
Contract Type FiledMarch 31st, 2010 Company Industry JurisdictionThis Mutual Termination and Release Agreement (“Release”) is entered into on January 28, 2010 (“Closing Date”) with an effective date of January 31, 2010 (“Effective Date”) between Health Discovery Corporation, a Georgia corporation (“HDC”), and DCL Medical Laboratories, LLC, a Delaware limited liability company (“DCL”), collectively referred to as the “Parties.”